United States · Bill · S
S. 2103 (116th)
Affordable Insulin Approvals Now Act
Introduced
11 July 2019
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Affordable Insulin Approvals Now Act This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 11 July 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 11 July 2019
Introduced in Senate
summary · EN · 11 July 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/2103
- Open data entity: https://api.congress.gov/v3/bill/116/s/2103